Methods: Between February 2018 and March 2022, a total of 60 patients (49 male, 11 female; mean age, 23.5±8.8 days; range, 2 to 106 days) who were operated with a diagnosis of simple transposition of the great arteries and discharged uneventfully were included. Preoperative balloon atrial septostomy was performed in 33 patients (BAS+ group), while 27 patients (BAS? group) did not undergo the procedure. Finally, 13 patients from the septostomy group and 12 patients from the non-septostomy group were available for follow-up. Neurodevelopment in infants was assessed using the 3rd edition of the Bayley Scales of Infant and Toddler Development (Bayley-III) scoring.
Results: The mean cognitive, language, and motor composite scores were 85.00±11.73, 89.62±12.29, and 83.38±14.83 in the BAS+ group and 94.58±18.40, 99.83±15.71, and 90.00±18.73 in the BAS- group, respectively (p=0.131, p=0.123, and p=0.689, respectively). Ballon atrial septostomy was the only factor that caused a decrease in all composite scores according to Bayley-III scoring, although not statistically significant. There was a significant negative correlation between C-reactive protein and all composite scores. There was also a significant negative correlation between cardiopulmonary bypass time, cross-clamping time, mean plasma lactate levels (mmol/L) on postoperative Days 2-5, postoperative creatinine, and motor composite scores. There was a significant positive correlation between growth weight and head circumference and all three CSs.
Conclusion: Ballon atrial septostomy may adversely affect the neurodevelopmental process in neonates. We believe that close monitoring of postoperative blood values such as lactate, C-reactive protein and creatinine, and avoiding hypoxemia and keeping them at optimal levels are crucial. Good weight gain can also contribute to the neurodevelopment of patients.
McQuillen et al.[7] identified balloon atrial septostomy (BAS) as an important risk factor for preoperative focal brain damage in newborns with transposition of the great arteries (TGA).[7] Children with CHD demonstrate a high prevalence of developmental disorder, disabilities or developmental delay.[8] There are also studies that associate critical CHDs such as TGA with neurodevelopmental disorders and evaluate this as a process that begins in utero.[8-16] Studies on neurodevelopmental outcome in CHD are predominantly conducted in newborns with TGA. Individuals with TGA represent a unique and relatively homogeneous study cohort with the arterial switch operation (ASO) being now the standard-of-care. The only genetic syndrome with a strong relation with TGA is heterotaxy. Critical factors such as the rarity of the neurodevelopmental delay that may develop due to the genetic syndrome and the fact that there is a currently accepted standard surgical treatment make it easier to isolate the perioperative factors affect neurodevelopmental outcomes for patients with TGA.[17-19]
In the present study, we aimed to investigate the effect of preoperative BAS and intraoperative parameters on neurodevelopmental outcomes in patients operated for TGA using the Bayley-III scoring.
A pediatric cardiologist evaluated all neonates with TGA preoperatively to determine the need for a BAS. The indication for BAS was based on systemic arterial oxygen saturation (SaO2), clinical assessment of cardiac output, and patency/size of the interatrial communication by echocardiography.[7] Typically, BAS was performed in the cardiac catheterization laboratory under fluoroscopic guidance with hemodynamic monitoring. Medical records of the patients were reviewed retrospectively to determine the accuracy and completeness of the information available. Afterwards, nine months and older children were invited to the Child Development outpatient clinic to assess their neurodevelopment using the Bayley-III scoring system. Follow-up status for neurodevelopment was considered to be incomplete, if the parents of the patients did not answer any call attempts or refused to participate in the study. Finally, 13 patients in the septostomy group (BAS+) and 12 patients in the non-septostomy group (BAS?) were admitted to the outpatient clinic to assess their neurodevelopment. The neurodevelopment of these two groups was evaluated and the parameters that may affect this development were investigated. The Bayley-III, (Bayley-III? Screening Test, PsychCorp-Harcourt, Brace, & Co, TX, USA) was administered. The scale consists of three primary composite standard scores, the cognitive, motor, and language composite scores (CS), measured by performance of specified tasks, and scored against a normative population, scaled to have a mean score of 100 with standard deviation of 15. The age of the patients at the time of the application of the CS tests ranged between nine and 44 months. In addition, an extensive parental questionnaire was administered. Socioeconomic status was classified as below minimum wage, minimum wage, and above minimum wage. These tests were administered by a single developmental behavioral pediatrician. The Bayley-III cognitive, language, and motor CS were completed for all patients.[6] Cognitive, language or motor CS <85 was taken as mild impairment /at risk of development delay.[20]
Statistical analysis
Statistical analysis was performed using the
IBM SPSS version 22.0 software (IBM Corp.,
Armonk, NY, USA). Continuous data were presented
in mean ± standard deviation (SD) or median
(min-max), while categorical data were presented in
number and frequency. The Pearson chi-square test
was used to compare categorical variables between
groups. In cases where a significant difference was
observed, the Bonferroni correction was applied as
a post-hoc analysis. The conformity of continuous variables to normal distribution was evaluated
by the Shapiro-Wilk test. The Student t-test was
used for variables with normal distribution and
Mann-Whitney U test was used for variables without
normal distribution. The Pearson correlation test
was used for variables with normal distribution and
Spearman correlation test was used for variables
without normal distribution. Linear regression
analysis was applied to determine the predictors
of neurological values. The enter method was used
to create the model and those with significant
correlation in the correlation test were included
in the model. A p value of <0.05 was considered
statistically significant.
Table 1. Comparison of all parameters according to preoperative need for BAS
Although there was a significant positive correlation between cognitive CS and hemoglobin, growth weight, head circumference (Z-score), there was a significant negative correlation between cognitive CS and C-reactive protein (CRP) (r=?0.467, p=0.021). There was a significant positive correlation between language CS and gestational age (weeks), lowest arterial pH, growth weight and head circumference (Z-score) and a significant negative correlation between language CS and CRP (r=?0.444, p=0.030). There was a significant positive correlation between motor CS and growth weight, length and head circumference (Z-score), and a significant negative correlation between motor CS and cardiopulmonary bypass (CPB) time (min), cross-clamping (CC) time (min), mean plasma lactate (mmol/L) on postoperative Days 2-5, creatinine (CRE) and CRP (r=?0.493, p=0.014) (Table 2).
According to the multiple linear regression analysis, cognitive CS could predict language CS (β=0.588, p<0.001) and motor CS (β=0.332, p=0.005). Language CS predicted cognitive CS (β=0.636, p<0.001) (Table 3).
In their study, McQuillen et al.[7] identified BAS as an important risk factor for preoperative acquired brain injury in neonates with TGA. Although we were unable to find statistically significant difference in our study, all three cognitive, language and motor CS were significantly lower in the BAS+ group. Of note, we cannot exclude the fact that the patients who underwent BAS were more exposed to hypoxia and cyanosis in this process; however, we had two groups that were balanced in terms of parameters affecting neurodevelopment in many respects, except for the socioeconomic status. Initially, 25 patients (13 BAS+, 12 BAS-) were admitted to Child Development outpatient clinic and their neurodevelopmental process was evaluated using the Bayley-III scoring system. Their data and its relation with CS and BAS were calculated statistically and we reached some conclusions that may be related to neurodevelopment. First, BAS was the only factor that caused a significant decrease in all three of the cognitive, language and motor CS according to Bayley-III scoring, although not statistically significant. The mean cognitive, language, motor CS were 85.00±11.73, 89.62±12.29, 83.38±14.83, respectively in the BAS+ group and 94.58±18.40, 99.83±15.71, 90.00±18.73, respectively in the BAS- group.
In the current study, we also observed a significant negative correlation between CRP, a routine blood test taken postoperatively in NICU, and all three cognitive, language and motor CS. There is also evidence that CRP, a marker of systemic inflammation, is associated with an increased risk for cognitive decline in adults.[21] There was a significant negative correlation between CPB and CC time, the mean plasma lactate (mmol/L) on postoperative Days 2-5, postoperative CRE and motor CS. However, Algra et al.[22] found no statistically significant relation between CPB time, the mean-highest arterial lactate (mmol/L), and new white matter injury in their cohort. There was a significant positive correlation between growth weight and head circumference (Z-score) and all three cognitive, language, and motor CS.
In another study, Acton et al.[23] evaluated a different ASO cohort from our study, using the Bayley-III. The mean cognitive composite standard score was 101.4±1.6, language composite standard score was 97.4±17.2, and motor composite standard score was 99.8±10.5. In their study, deep hypothermic circulatory arrest was used as the surgical technique in approximately 70% of the cohort. Patients who required ECMO and those with chromosomal abnormalities were excluded.
As improvements in neonatal heart surgery have allowed us to significantly lower operative mortality, a normal neurodevelopment has become an equally important goal. Andropoulos et al.[24] reported their neurological outcomes after neonatal ASO. They had 100% survival rate and favorable neurodevelopmental outcomes (cognitive: 104.8±15.0, language: 90.0 [83.0-94.0], motor: 92.3±14.2), consistent with our findings. The authors emphasized the importance of pre-, intra-, and postoperative monitoring of regional cerebral oxygen saturation, and keeping that saturation above 50%. In our cohort, we attribute the relatively low CS in the BAS+ group to preoperative low oxygen levels. Also, we had a non-modifiable factor such as socioeconomic status. The socioeconomic status of the BAS+ group was significantly lower than the socioeconomic status of the BAS- group, which probably contributed to the low CS in the BAS+ group.
Comparison of the current patient cohort with previous reports of neurodevelopmental outcomes in neonatal ASO patients is problematic, as previous versions of the BSID are significantly different and direct transfer of scores between different versions is not possible.[23,25] However, the developmental pediatrics and psychological experts, including our own coauthor, caution against this and would state that the Bayley-III really is more comprehensive test. Currently, the Bayley-III is the most frequently used standardized developmental tool for assessing development in infancy and early childhood in both clinical practice and research settings. It provides more detailed and precise information than BSID-II in terms of separately evaluating the child's cognitive, receptive language, expressive language, fine motor and gross motor skills.[6] Celik et al.[26] conducted a study comparing BSID-II and Bayley-III in Turkish children and commented that the scores in Bayley-III were relatively higher than those in BSID-II. However, there is also literature describing an overestimation of neurodevelopmental problems with the BSID-II.[23,27,28] While approximately 10% of the standardization of Bayley-III has been done in children with developmental difficulties or delays, the standardization of BSID-II has been done completely in healthy children. This may result higher rates of developmental delay in BSID-II. In other words, BSID-II may have been mildly pessimistic.[29]
In our center, the ASO for simple TGA is performed during the first two weeks of life, except in the setting of prematurity or when preoperative complications delay surgery. Mortality rates in this patient group tend to decrease and it is becoming more important for patients to live with normal neurodevelopment.[24] In our cohort, children after ASO had neurodevelopmental outcomes at expected levels for their age. This once again emphasizes the importance of perioperative care. We believe that close monitoring of postoperative blood values such as lactate, CRP, CRE, avoiding hypoxemia and keeping them at optimal levels are of utmost importance. Good weight gain can also contribute to the neurodevelopment of patients. Consistent with the literature, we believe that BAS has a negative effect on development.
Nonetheless, there are some limitations to this study. There is growing evidence supporting that anatomical and functional neurodevelopmental impairments, which possibly caused by impaired oxygen distribution to the brain, are also present before surgery indicated by magnetic resonance imaging (MRI) findings.[30] This may be a limitation for us, as we have no MRI findings in our study. The wide age range between nine and 44 months may be another limitation. The small size of the cohort also should be noted since it confines the strength of our results.
In conclusion, close monitoring of postoperative blood values such as lactate, C-reactive protein and creatinine, and avoiding hypoxemia and keeping them at optimal levels are crucial in this group of patients. Good weight gain can also contribute to the neurodevelopment of patients and balloon atrial septostomy may adversely affect the neurodevelopmental process. Further multi-center, large-scale, prospective studies are needed to confirm these findings and to aid in designing appropriate interventional trials.
Data Sharing Statement: The data that support the findings of this study are available from the corresponding author upon reasonable request.
Author Contributions: Idea/concept: B.A., Y.K.; Design, literature review Ş.G.B., Y.K.; Control/supervision, analysis and/ or interpretation, writing the article, critical review, references and fundings: Y.K.; Data collection and/or processing, materials: Ş.G.B., Ö.G., Y.K.
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Funding: The authors received no financial support for the research and/or authorship of this article.
1) Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, et al.
Global birth prevalence of congenital heart defects 1970-
2017: Updated systematic review and meta-analysis of 260
studies. Int J Epidemiol 2019;48:455-63. doi: 10.1093/ije/
dyz009.
2) Marelli A, Miller SP, Marino BS, Jefferson AL, Newburger
JW. Brain in congenital heart disease across the lifespan: The
cumulative burden of injury. Circulation 2016;133:1951-62.
doi: 10.1161/CIRCULATIONAHA.115.019881.
3) Snookes SH, Gunn JK, Eldridge BJ, Donath SM, Hunt RW,
Galea MP, et al. A systematic review of motor and cognitive
outcomes after early surgery for congenital heart disease.
Pediatrics 2010;125:e818-27. doi: 10.1542/peds.2009-1959.
4) McQuillen PS, Miller SP. Congenital heart disease and
brain development. Ann N Y Acad Sci 2010;1184:68-86. doi:10.1111/j.1749-6632.2009.05116.x.
5) Bayley N. Bayley scales of infant development manual. 2nd
ed. San Antonio, TX: The Psychological Corporation; 1993.
6) Bayley N. Bayley scales of infant and toddler development
manual. 3rd ed. San Antonio, TX: The Psychological
Corporation; 2006.
7) McQuillen PS, Hamrick SE, Perez MJ, Barkovich AJ,
Glidden DV, Karl TR, et al. Balloon atrial septostomy
is associated with preoperative stroke in neonates with
transposition of the great arteries. Circulation 2006;113:280-5. doi: 10.1161/CIRCULATIONAHA.105.566752.
8) Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes
M, Gaynor JW, et al. Neurodevelopmental outcomes in
children with congenital heart disease: Evaluation and
management: A scientific statement from the American
Heart Association. Circulation 2012;126:1143-72. doi:10.1161/CIR.0b013e318265ee8a.
9) Ballweg JA, Wernovsky G, Gaynor JW. Neurodevelopmental
outcomes following congenital heart surgery. Pediatr Cardiol
2007;28:126-33. doi: 10.1007/s00246-006-1450-9.
10) Bellinger DC, Jonas RA, Rappaport LA, Wypij D, Wernovsky
G, Kuban KC, et al Developmental and neurologic status of
children after heart surgery with hypothermic circulatory
arrest or low-flow cardiopulmonary bypass. N Engl J Med
1995;332:549-55. doi: 10.1056/NEJM199503023320901.
11) Limperopoulos C, Majnemer A, Shevell MI, Rohlicek
C, Rosenblatt B, Tchervenkov C, et al. Predictors of
developmental disabilities after open heart surgery in young
children with congenital heart defects. J Pediatr 2002;141:51-8. doi: 10.1067/mpd.2002.125227.
12) Wernovsky G. Current insights regarding neurological and
developmental abnormalities in children and young adults
with complex congenital cardiac disease. Cardiol Young
2006;16 Suppl 1:92-104. doi: 10.1017/S1047951105002398.
13) Masoller N, Martínez JM, Gómez O, Bennasar M, Crispi
F, Sanz-Cortés M, et al. Evidence of second-trimester
changes in head biometry and brain perfusion in fetuses
with congenital heart disease. Ultrasound Obstet Gynecol
2014;44:182-7. doi: 10.1002/uog.13373.
14) Scherjon SA, Smolders-DeHaas H, Kok JH, Zondervan
HA. The "brain-sparing" effect: Antenatal cerebral Doppler
findings in relation to neurologic outcome in very preterm
infants. Am J Obstet Gynecol 1993;169:169-75. doi:10.1016/0002-9378(93)90156-d.
15) Donofrio MT, Bremer YA, Schieken RM, Gennings C,
Morton LD, Eidem BW, et al. Autoregulation of cerebral
blood flow in fetuses with congenital heart disease: The
brain sparing effect. Pediatr Cardiol 2003;24:436-43. doi:10.1007/s00246-002-0404-0.
16) Kaltman JR, Di H, Tian Z, Rychik J. Impact of congenital
heart disease on cerebrovascular blood flow dynamics in
the fetus. Ultrasound Obstet Gynecol 2005;25:32-6. doi:10.1002/uog.1785.
17) Dunbar-Masterson C, Wypij D, Bellinger DC, Rappaport LA,
Baker AL, Jonas RA, et al. General health status of children with D-transposition of the great arteries after the arterial
switch operation. Circulation 2001;104:I138-42. doi: 10.1161/
hc37t1.094782.
18) Bellinger DC, Wypij D, duPlessis AJ, Rappaport LA, Jonas
RA, Wernovsky G, et al. Neurodevelopmental status at eight
years in children with dextro-transposition of the great
arteries: The Boston Circulatory Arrest Trial. J Thorac
Cardiovasc Surg 2003;126:1385-96. doi: 10.1016/s0022-
5223(03)00711-6.
19) Karl TR, Hall S, Ford G, Kelly EA, Brizard CP, Mee RB, et
al. Arterial switch with full-flow cardiopulmonary bypass
and limited circulatory arrest: Neurodevelopmental outcome.
J Thorac Cardiovasc Surg 2004;127:213-22. doi: 10.1016/j.
jtcvs.2003.06.001.
20) Del Rosario C, Slevin M, Molloy EJ, Quigley J, Nixon E. How
to use the Bayley Scales of Infant and Toddler Development.
Arch Dis Child Educ Pract Ed 2021;106:108-12. doi: 10.1136/
archdischild-2020-319063.
21) Laurin D, David Curb J, Masaki KH, White LR, Launer LJ.
Midlife C-reactive protein and risk of cognitive decline: A 31.year follow-up. Neurobiol Aging 2009;30:1724-7. doi:10.1016/j.neurobiolaging.2008.01.008.
22) Algra SO, Jansen NJ, van der Tweel I, Schouten AN,
Groenendaal F, Toet M, et al. Neurological injury after
neonatal cardiac surgery: A randomized, controlled trial of
2 perfusion techniques. Circulation 2014;129:224-33. doi:10.1161/CIRCULATIONAHA.113.003312.
23) Acton BV, Biggs WS, Creighton DE, Penner KA, Switzer
HN, Thomas JH, et al. Overestimating neurodevelopment
using the Bayley-III after early complex cardiac surgery.
Pediatrics 2011;128:e794-800. doi: 10.1542/peds.2011-0331.
24) Andropoulos DB, Easley RB, Brady K, McKenzie ED,
Heinle JS, Dickerson HA, et al. Changing expectations for
neurological outcomes after the neonatal arterial switch
operation. Ann Thorac Surg. 2012;94:1250-5. doi: 10.1016/j.
athoracsur.2012.04.050.
25) Goldstone AB, Baiocchi M, Wypij D, Stopp C, Andropoulos
DB, Atallah J, et al. The Bayley-III scale may underestimate
neurodevelopmental disability after cardiac surgery in
infants. Eur J Cardiothorac Surg 2020;57:63-71. doi: 10.1093/
ejcts/ezz123.
26) Çelik P, Sucaklı İA, Yakut Hİ. Which Bayley-III cut-off
values should be used in different developmental levels? Turk
J Med Sci 2020:50: 764-770. doi: 10.3906/sag-1910-69.
27) Picciolini O, Squarza C, Fontana C, Giannì ML, Cortinovis
I, Gangi S, et al. Neurodevelopmental outcome of extremely
low birth weight infants at 24 months corrected age: A
comparison between Griffiths and Bayley Scales. BMC
Pediatr 2015;15:139. doi: 10.1186/s12887-015-0457-x.
28) O'Shea TM, Joseph RM, Allred EN, Taylor HG, Leviton
A, Heeren T, et al. Accuracy of the Bayley-II mental
development index at 2 years as a predictor of cognitive
impairment at school age among children born extremely
preterm. J Perinatol 2018;38:908-16. doi: 10.1038/s41372-
017-0020-8.